EagleClaw Capital Managment LLC Buys 300 Shares of Colgate-Palmolive (NYSE:CL)

EagleClaw Capital Managment LLC boosted its position in shares of Colgate-Palmolive (NYSE:CL) by 0.9% during the third quarter, Holdings Channel.com reports. The fund owned 32,879 shares of the company’s stock after acquiring an additional 300 shares during the quarter. EagleClaw Capital Managment LLC’s holdings in Colgate-Palmolive were worth $3,413,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. E Fund Management Hong Kong Co. Ltd. purchased a new position in shares of Colgate-Palmolive during the 2nd quarter valued at $25,000. Continuum Advisory LLC raised its holdings in Colgate-Palmolive by 46.5% during the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock valued at $38,000 after acquiring an additional 125 shares during the period. Reston Wealth Management LLC purchased a new position in shares of Colgate-Palmolive in the third quarter valued at about $42,000. Capital Performance Advisors LLP bought a new position in shares of Colgate-Palmolive in the third quarter worth about $53,000. Finally, Prospera Private Wealth LLC purchased a new stake in shares of Colgate-Palmolive during the third quarter worth about $64,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Down 0.6 %

Shares of Colgate-Palmolive stock traded down $0.59 during trading on Wednesday, hitting $93.02. The stock had a trading volume of 89,581 shares, compared to its average volume of 4,371,565. Colgate-Palmolive has a 12 month low of $75.39 and a 12 month high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The firm’s fifty day simple moving average is $98.80 and its 200-day simple moving average is $98.56. The stock has a market cap of $76.00 billion, a PE ratio of 26.82, a PEG ratio of 3.34 and a beta of 0.42.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $2.00 annualized dividend and a dividend yield of 2.15%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on CL. UBS Group upped their price target on Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a research note on Wednesday, September 4th. Stifel Nicolaus lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their target price for the stock from $105.00 to $101.00 in a research report on Monday, October 28th. Redburn Atlantic upgraded shares of Colgate-Palmolive to a “hold” rating in a report on Thursday, August 1st. Wells Fargo & Company dropped their price objective on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating for the company in a report on Monday, October 28th. Finally, TD Cowen reduced their target price on Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating on the stock in a report on Monday, October 28th. One analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $105.11.

Insider Activity

In related news, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the transaction, the director now owns 11,755 shares in the company, valued at $1,220,874.30. The trade was a 16.44 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.37% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.